Cancer Therapy–related Hepatic Injury in Children: Imaging Review from the Pediatric LI-RADS Working Group
Authors:
- Cara E. MorinCMCara E. Morin
- Amy B. KolbeAKAmy B. Kolbe
- Adina AlazrakiAAAdina Alazraki
- Govind B. ChavhanGCGovind B. Chavhan
- Annie GillAGAnnie Gill
- Juan InfanteJIJuan Infante
- Geetika KhannaGKGeetika Khanna
- HaiThuy N. NguyenHNHaiThuy N. Nguyen
- Allison F. O'NEillAOAllison F. O'NEill
- Mitchell A. ReesMRMitchell A. Rees
- Akshay SharmaASAkshay Sharma
- James E. SquiresJSJames E. Squires
- 1 September 2023
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (9) , e230007
Abstract
The liver is the primary organ for the metabolism of many chemotherapeutic agents. Treatment-induced liver injury is common in children undergoing cancer therapy. Hepatic injury occurs due to various mechanisms, including biochemical cytotoxicity, hepatic vascular injury, radiation-induced cytotoxicity, and direct hepatic injury through minimally invasive and invasive surgical treatments. Treatment-induced liver injury can be seen contemporaneous with therapy and months to years after therapy is complete. Patients can develop a combination of hepatic injuries manifesting during and after treatment. Acute toxic effects of cancer therapy in children include hepatitis, steatosis, steatohepatitis, cholestasis, hemosiderosis, and vascular injury. Longer-term effects of cancer therapy include hepatic fibrosis, chronic liver failure, and development of focal liver lesions. Quantitative imaging techniques can provide useful metrics for disease diagnosis and monitoring, especially in treatment-related diffuse liver injury such as hepatic steatosis and steatohepatitis, hepatic iron deposition, and hepatic fibrosis. Focal liver lesions, including those developing as a result of treatment-related vascular injury such as focal nodular hyperplasia-like lesions and hepatic perfusion anomalies, as well as hepatic infections occurring as a consequence of immune suppression, can be anxiety provoking and confused with recurrent malignancy or hepatic metastases, although there often are imaging features that help elucidate the correct diagnosis. Radiologic evaluation, in conjunction with clinical and biochemical screening, is integral to diagnosing and monitoring hepatic complications of cancer therapy in pediatric patients during therapy and after therapy completion for long-term surveillance. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material See the invited commentary by Ferraciolli and Gee in this issue.Keywords
This publication has 71 references indexed in Scilit:
- Hepato‐biliary late effects in survivors of childhood and adolescent cancer: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2010
- Ferritin for the clinicianBlood Reviews, 2009
- Liver biopsy results in patients with sickle cell disease on chronic transfusions: Poor correlation with ferritin levelsPediatric Blood & Cancer, 2007
- Magnetic resonance imaging measurement of iron overloadCurrent Opinion in Hematology, 2007
- CT Features of Hepatic Venoocclusive Disease and Hepatic Graft-Versus-Host Disease in Patients After Hematopoietic Stem Cell TransplantationAmerican Journal of Roentgenology, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatmentLeukemia Research, 2005
- Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)Seminars in Liver Disease, 2002
- Dark ring sign: Finding in patients with fungal liver lesions and transfusional hemosiderosis undergoing treatment with antifungal antibioticsMagnetic Resonance Imaging, 1996
- Terminology of nodular hepatocellular lesionsHepatology, 1995